Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Orion (4) is one of MSF’s patients in Tajikistan, one of Asia’s poorest countries, where we run a paediatric TB program. MSF Doctor Ioanna Haziri listens to Orion's lungs and breathing during her check-up of the little boy. Photograph by Wendy Marijnissen
Feature story
Feature story |
07 November 2013
Tuberculosis
Tajikistan

A Boy's Family Joins MSF to Help Him Fight TB Meningitis

5-year-old Umeda has MDR-TB. She is staying with her aunt while her parents are visiting family in another district. Photograph by Wendy Marijnissen
Feature story
Feature story |
07 November 2013
Tuberculosis
Tajikistan

A 5-Year-Old Undergoes MDR-TB Treatment in Tajikistan

3 min
 Tessy was in charge of a measles vaccination campaign in DRC for 2 months (June to August 2013). Since 2010, the country is affected by a measles epidemic. 200,000 people were affected. 4,500 died among which many were children. Since 2 years, 4 million people were vaccinated by MSF thanks to the collaboration of the local health authorities. Photograph by Christophe Hebting
Feature story
Feature story |
23 September 2013
Vaccines
Democratic Republic of the Congo

DRC: Innovative vaccination strategies to respond to measles epidemic

5 min
Phumeza Tisile, 23 years celebrates her cure from XDR-TB with friends and patients at Lizo Nobanda TB Care Centre, Khayelitsha, South Africa on August 16, 2013. Photo by Sydelle Willow Smith
Feature story
Feature story |
29 August 2013
Tuberculosis

Not Another TB Statistic: Ending My Journey with XDR-TB

5 min
48-year old Linda Vilakati is one of 55 patients who have just successfully completed treatment for MDR-TB in Swaziland. Linda is sitting with his former treatment supporter, Nonhlanhla Zikalala, who helped see him through his recovery. Photograph by Zanele Zwane
Feature story
Feature story |
12 August 2013
Tuberculosis

Swaziland: First group of MDR-TB patients celebrate end of treatment

3 min
Feature story |
23 July 2013
Tropical & neglected diseases
Democratic Republic of the Congo

Insects Without Borders: Barrie Rooney in Democratic Republic of Congo

5 min
Abéché inhabitants are queuing to get their children vaccinated. Photograph by Flora Escourrou
Feature story
Feature story |
05 July 2013
Vaccines
Chad

Chad: "We had Two Weeks to Vaccinate 100,000 Children"

4 min
"Starting on antiretrovirals was quite difficult - I didn't have very bad side effects, but I lost appetite. But after four months I started feeling a change. I became strong. I could now stand for long hours. I went out to look for work and got a job as a social worker at a school for children orphaned by the HIV epidemic, 2005, Kenya. Photograph by Charles
Feature story
Feature story |
21 June 2013

5 portraits 2013

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury